Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Roche's oral SERD notches second pivotal breast cancer win - FirstWord Pharma
Roche's oral SERD notches second pivotal breast cancer win FirstWord Pharma
OLMA Stock Doubles After Roche Cancer Drug Trial Yields Positive Results - Stocktwits
OLMA Stock Doubles After Roche Cancer Drug Trial Yields Positive Results Stocktwits
Roche's oral SERD goes 2 for 2, hitting goal in phase 3 adjuvant breast cancer trial - Fierce Biotech
Roche's oral SERD goes 2 for 2, hitting goal in phase 3 adjuvant breast cancer trial Fierce Biotech
Roche touts early giredestrant success | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Roche touts early giredestrant success | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Roche boosts Olema as breast cancer therapy succeeds in late-stage trial - Seeking Alpha
Roche boosts Olema as breast cancer therapy succeeds in late-stage trial Seeking Alpha
Is Now the Moment to Reassess Roche After Its Drug Pipeline Developments and 17% Stock Jump? - simplywall.st
Is Now the Moment to Reassess Roche After Its Drug Pipeline Developments and 17% Stock Jump? simplywall.st
Roche oral drug shown to keep breast cancer at bay, boosting shares - Reuters
Roche oral drug shown to keep breast cancer at bay, boosting shares Reuters
Roche Gives Glimpse of Cancer Genomics Potential of New Axelios Sequencer - GenomeWeb
Roche Gives Glimpse of Cancer Genomics Potential of New Axelios Sequencer GenomeWeb
Obituary information for Kathleen M. Roche - Cartmell Davis Funeral Home
Obituary information for Kathleen M. Roche Cartmell Davis Funeral Home
Roche’s fenebrutinib shows best-in-disease potential in MS - European Pharmaceutical Review
Roche’s fenebrutinib shows best-in-disease potential in MS European Pharmaceutical Review
Roche sizes up first BTK inhibitor approval on Phase III MS victory - Clinical Trials Arena
Roche sizes up first BTK inhibitor approval on Phase III MS victory Clinical Trials Arena
Artificial Intelligence at Roche Diagnostics - Emerj Artificial Intelligence Research
Artificial Intelligence at Roche Diagnostics Emerj Artificial Intelligence Research
Roche reports phase 3 multiple sclerosis wins for BTK inhibitor, succeeding where rivals failed - Fierce Biotech
Roche reports phase 3 multiple sclerosis wins for BTK inhibitor, succeeding where rivals failed Fierce Biotech